Regulatory Affairs Professionals Society· @RAPSorg · X·· 21 天前精选AI 评分50
AI 导读
美国FDA代理局长Kyle Diamantas称,该机构新的罕见病框架是现代化罕见病开发、将患者声音纳入孤儿疗法科学审评的最佳机制。相关链接指向RAPS的报道页面。
推荐理由
FDA代理局长将新罕见病框架定位为现代化开发与纳入患者声音的主要机制,读者可据此了解该监管思路的取向。
正文
Acting US FDA Commissioner Kyle Diamantas touted the agency’s new rare disease framework as the best mechanism for modernizing rare disease development and incorporating the patient voice into scientific reviews for orphan therapies.
https://hubs.la/Q04Cs3330
来源:Regulatory Affairs Professionals Society · x.com